(Q37731798)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20395631%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

review article

1 reference

title

Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20395631%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author

Jean-Michel Sallenave

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20395631%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Jean-Michel Sallenave

series ordinal

1

1 reference

22 August 2017

publication date

15 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20395631%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Respiratory Cell and Molecular Biology

31 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20395631%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20395631%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20395631%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

635-643

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20395631%20AND%20SRC:MED&resulttype=core&format=json

Role of innate immune cells and their products in lung immunopathology

31 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Neutrophil serine proteases fine-tune the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Metalloproteinases and their inhibitors: regulators of wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Lung cysteine cathepsins: intruders or unorthodox contributors to the kallikrein-kinin system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Leukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Molecular cloning and expression of cDNA for human antileukoprotease from cervix uterus

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

The acid-stable proteinase inhibitor of human mucous secretions (HUSI-I, antileukoprotease). Complete amino acid sequence as revealed by protein and cDNA sequencing and structural homology to whey proteins and Red Sea turtle proteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Characterization of a low molecular weight anti-elastase isolated from human bronchial secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Purifkation and Characterization of Elastase-Specific Inhibitor. Sequence Homology with Mucus Proteinase Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Isolation of elafin and elastase-specific inhibitor (ESI) from bronchial secretions. Evidence of sequence homology and immunological cross-reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Primary structure of the human elafin precursor preproelafin deduced from the nucleotide sequence of its gene and the presence of unique repetitive sequences in the prosegment

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

A secretory leukocyte proteinase inhibitor (SLPI)-like protein from Litopenaeus vannamei haemocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Characterization of the ovine ortholog of secretory leukoprotease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Trappin ovine molecule (TOM), the ovine ortholog of elafin, is an acute phase reactant in the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

The gene of the protease inhibitor SKALP/elafin is a member of the REST gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

The evolution of a genetic locus encoding small serine proteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Solution structure of R-elafin, a specific inhibitor of elastase

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

SLPI and elafin: one glove, many fingers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Human neutrophil elastase regulates the expression and secretion of elafin (elastase-specific inhibitor) in type II alveolar epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Cytokine-mediated induction of the human elafin gene in pulmonary epithelial cells is regulated by nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

The secretory leukocyte protease inhibitor gene is a target of epidermal growth factor receptor action in endometrial epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Differential regulation of secretory leukocyte protease inhibitor and elafin by progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Elafin in human endometrium: an antiprotease and antimicrobial molecule expressed during menstruation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Innate immune defences in the human uterus during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Transforming growth factor-beta1 is a potent inhibitor of secretory leukoprotease inhibitor expression in a bronchial epithelial cell line. Munich Lung Transplant Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Secretory leucoprotease inhibitor impairs Toll-like receptor 2- and 4-mediated responses in monocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Proteinase-activated receptor-2 and human lung epithelial cells: disarming by neutrophil serine proteinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Proteinase-activated receptor-1 mediates elastase-induced apoptosis of human lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Adenoviral gene delivery of elafin and secretory leukocyte protease inhibitor attenuates NF-kappa B-dependent inflammatory responses of human endothelial cells and macrophages to atherogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Elafin prevents lipopolysaccharide-induced AP-1 and NF-kappaB activation via an effect on the ubiquitin-proteasome pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

DNA from bronchial secretions modulates elastase inhibition by alpha(1)-proteinase inhibitor and oxidized secretory leukoprotease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Possible existence of common internalization mechanisms among arginine-rich peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Secretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

The protease inhibitor, elafin, induces p53-dependent apoptosis in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Mice lacking neutrophil elastase are resistant to bleomycin-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Supernatants of Pseudomonas aeruginosa induce the Pseudomonas-specific antibiotic elafin in human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

The antibacterial and antifungal properties of trappin-2 (pre-elafin) do not depend on its protease inhibitory function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Secretory leukocyte protease inhibitor: a secreted pattern recognition receptor for mycobacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Adenoviral augmentation of elafin protects the lung against acute injury mediated by activated neutrophils and bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Antimicrobial activity of murine lung cells against Staphylococcus aureus is increased in vitro and in vivo after elafin gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Human pre-elafin inhibits a Pseudomonas aeruginosa-secreted peptidase and prevents its proliferation in complex media

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Immunomodulation of nasal epithelial cells by Staphylococcus aureus-derived serine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

A novel secreted protease from Pseudomonas aeruginosa activates NF-kappaB through protease-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Helicobacter pylori-induced downregulation of the secretory leukocyte protease inhibitor (SLPI) in gastric epithelial cell lines and its functional relevance for H. pylori-mediated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Elafin is specifically inactivated by RgpB from Porphyromonas gingivalis by distinct proteolytic cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

House Dust Mite Der p 1 Downregulates Defenses of the Lung by Inactivating Elastase Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Neutrophil elastase converts human immature dendritic cells into transforming growth factor-beta1-secreting cells and reduces allostimulatory ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Regulation of pulmonary and systemic bacterial lipopolysaccharide responses in transgenic mice expressing human elafin

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

The antimicrobial antiproteinase elafin binds to lipopolysaccharide and modulates macrophage responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

The antimicrobial/elastase inhibitor elafin regulates lung dendritic cells and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Trappin-2 promotes early clearance of Pseudomonas aeruginosa through CD14-dependent macrophage activation and neutrophil recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Proteolytic susceptibility of the serine protease inhibitor trappin-2 (pre-elafin): evidence for tryptase-mediated generation of elafin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Bactericidal/permeability-increasing protein (BPI) and BPI homologs at mucosal sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

By Binding SIRPα or Calreticulin/CD91, Lung Collectins Act as Dual Function Surveillance Molecules to Suppress or Enhance Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Inhibition of airway proteases in cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Oxidized mucus proteinase inhibitor: a fairly potent neutrophil elastase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Proteinase/proteinase inhibitor imbalance in sputum sol phases from patients with chronic obstructive pulmonary disease. Suggestions for a key role played by antileukoprotease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Downregulation of secretory leukocyte proteinase inhibitor in chronic obstructive lung disease: the role of TGF-beta/Smads signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Role of secretory leukocyte protease inhibitor in the development of subclinical emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Neutrophil elastase (NE) and NE inhibitors: canonical and noncanonical functions in lung chronic inflammatory diseases (cystic fibrosis and chronic obstructive pulmonary disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Use of secretory leukoprotease inhibitor to augment lung antineutrophil elastase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Pulmonary deposition and disappearance of aerosolised secretory leucocyte protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Expression of the secretory leukoprotease inhibitor gene in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Plasma neutrophil elastase and elafin imbalance is associated with acute respiratory distress syndrome (ARDS) development

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Genetic polymorphisms of peptidase inhibitor 3 (elafin) are associated with acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Identification of novel functional sequence variants in the gene for peptidase inhibitor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

SKALP/elafin gene polymorphisms are not associated with pustular forms of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Alpha one antitrypsin deficiency: from gene to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Immune responses to recombinant adeno-associated virus vectors: putting preclinical findings into perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Gene transfer to the lung: lessons learned from more than 2 decades of CF gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Transcriptionally targeted adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Production of biologically active CXC chemokines by Lactococcus lactis: evaluation of its potential as a novel mucosal vaccine adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Regulation of Adenovirus-Mediated Elafin Transgene Expression by Bacterial Lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

Inflammatory Lung Secretions Inhibit Dendritic Cell Maturation and Function via Neutrophil Elastase

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2010-0095RT

21 January 2018

Identifiers

DOI

10.1165/RCMB.2010-0095RT

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20395631%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference